Address
SalaryOur mission is to make biology easier to engineer. Ginkgo is constructing, editing, and redesigning the living world in order to answer the globe’s growing challenges in health, energy, food, materials, and more. Our bioengineers make use of an in-house automated foundry for designing and building new organisms.
Our Codebase team of Organism Engineers (OEs) is the core of Ginkgo’s strain engineering platform. We believe biology is a unique engineering substrate that comes pre-loaded with startlingly brilliant code we didn't write. Enabled by our high-throughput foundry, we study and design the most efficient way to create a new organism using the most advanced molecular biology techniques. We also employ various -omics technologies for understanding, troubleshooting, and debottlenecking our designed systems.
We are looking for highly talented and motivated Organism Engineers to join our development processes, including strain design, DNA/strain construction, evaluation of strain performance, and pathway optimization and troubleshooting. The internal title for this position is Organism Engineer 2.
Please note that this position could be at either our Seaport or Cambridge location.
Responsibilities:
- Genetic design and construction of strains to optimize production of chemicals and enzymes
- Using software and leveraging high-throughput robotics to assist in strain construction
- Developing suitable cultivation conditions and assays for screening the performance of your microbes
- Testing the metabolic and physiological performance of your microbes
- Analyzing data to identify limitations and bottlenecks in the performance of your microbes and e-designing strains based on the above
Minimum Requirements:
- BS in microbiology, biochemistry, genetics, chemical or biological engineering with 2+ years relevant experience, or MS with equivalent experience related to microbial metabolism
- Prior experience with metabolic engineering of industrial yeasts, prokaryotes or filamentous fungi
- Prior experience using automated workflows and associated software a plus
- Demonstrated history of limitless enthusiasm for synthetic biology and making biology easier to engineer
#LI-MB1
- What is it really like to take your company public via a SPAC? One Boston biotech shares its journey (Fortune)
- Ginkgo Bioworks resizes the definition of going big in biotech, raising $2.5B in a record SPAC deal that weighs in with a whopping $15B-plus valuation (Endpoints News)
- Ginkgo Bioworks CEO on scaling up Covid-19 testing: ‘If we try, we can win’ (CNBC)
- Ginkgo raises $70 million to ramp up COVID-19 testing for employers, universities (Boston Globe)
- Ginkgo Bioworks Redirects Its Biotech Platform to Coronavirus (Wall Street Journal)
- Ginkgo Bioworks Provides Support on Process Optimization to Moderna for COVID-19 Response (PRNewswire)
- The Life Factory: Synthetic Organisms From This $1.4 Billion Startup Will Revolutionize Manufacturing (Forbes)
- Synthetic Bio Pioneer Ginkgo Raises $290 Million in New Funding (Bloomberg)
- Ginkgo Bioworks raises $350 million fund for biotech spinouts (Reuters)
- Can This Company Convince You to Love GMOs? (The Atlantic)
